Physician's Weekly

JUNE 26, 2025

This starts with recognition that obesity is a chronic disease. When a child has risk factors but has not developed the disease, we must continue to provide preventive care and support for the family and appropriately match intensity and dose of the intervention. What modifications would you recommend to clinicians?

Families 52

Families Family Preventive Care Preventative Care 52

Today's Hospitalist

JUNE 7, 2025

THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. That’s according to two internists who work closely with hospitalized patients who take GLP-1s.

Hospital 66

Hospital Management Diabetes Patients 66

GeriPal

JANUARY 16, 2025

These individuals may become unrepresented, meaning they lack the capacity to make a specific medical decision, do not have an advance directive for that decision, and do not have a surrogate to help. How should we care for unrepresented individuals in inpatient and outpatient settings? Why not use the older term unbefriended?

Patient-Centered 109

Patient-Centered IT Patients Healthcare 109